Newest Zofran Birth Defect Lawsuit Filings Claim Anti-Nausea Drug Caused Cleft Palate, Other Defects, Accordingto Bernstein Liebhard LLP.

These cases include a claim filed on March 6[sup.th] in

California's Alameda Superior Court that alleges prenatal Zofran

exposure caused a little boy to suffer a heart rhythm problem called

supraventricular tachycardia. District Court,

District of Montana on April 3, 2015 claims that a baby born in 1998

sustained a cleft palate due to her mother's use of Zofran in the

first trimester. District Court, Northern

District of Alabama, alleges that prenatal exposure to Zofran was

responsible fora number of serious birth defects. Liebhard.

Parents of children who were born with serious birth defects

allegedly related to their mother's use of Zofran during pregnancy

may be entitled to file their own claims against GlaxoSmithKline.To find

out more about available legal options, please visit Bernstein Liebhard

LLP's website, or call the Firm directly at (888) 340-4807.

*sciencedirect.com/science/article/pii/S0002937814008539, American

Journal of Obstetrics and Gynecology, August 17, 2014

About Bernstein Liebhard LLP Bernstein Liebhard LLP is a New

York-based law firm exclusively representing injured persons in complex

individual and class action lawsuits nationwide since 1993. In response to the growing litigationinvolving Zofran

and birth defects, the Firm is now accepting inquiries from families

whose child was allegedly born with a serious congenital abnormality due

to pre-natal exposure to Zofran.

Other Zofran Lawsuits

Court records indicate that at least three other Zofran lawsuits are

pending in U.S. The Firm has been named zofran lawsuit payout by The National Law Journal to

the Plaintiffs' Hot List, recognizing the top plaintiffs firms in

the country, for the past 12 consecutive years. Among other things, the lawsuit seeks compensationfor

the 10 surgeries she has undergone to correct the problem.

(1:15-cv-00026-SPW-CSO)

"Like other recent Zofran lawsuit filings, court records

indicate that these complaints accuse GlaxoSmithKline of concealing the

association between Zofran and birth defects, and of improperly

marketing the medication to relieve pregnancy-related nausea and

vomiting," says Sandy A. RG15761042) A case filed on

February 16[sup.th] in U.S. According to court records, a

complaint filed on April 1[sup.st] in the U.S. The law firm

responsible for this advertisement is http://www.drugs.com/pro/zofran.html Bernstein Liebhard LLP,10 East

40th Street, New York, New York 10016, (888) 340-4807. (Case

2:15-cv-00709-PDC)

All of these lawsuits point out that Zofran, known generically as

ondansetron, is only approved to prevent nausea and vomiting experienced

by post-operative surgery patients, as well as cancer patients

undergoing certain types of chemotherapy and radiation. NEW YORK, April 10, 2015 /PRNewswire/ -- Zofran birth defect lawsuits

continue to mount in courts around the country, after two families came

forward with new cases last week. courts, all of which claim that use of the drug in early

pregnancy increases the risk that a baby will be born with a serious

birth defect. (Case No. Bernstein Liebhard LLP

info (at)consumerinjurylawyers(dot)com http://www.zofranlawsuit2015.com/

https://plus.google.com/115936073311125306742?rel=author

Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

To view the original version on PR Newswire,

visit:http://www.prnewswire.com/news-releases/newest-zofran-birth-defect-lawsuit-filings-cl-im-anti-nausea-drug-caused-cleft-palate-other-defects-according-to-bernstein-liebhard-llp-300064040.html/a

SOURCE Bernstein Liebhard LLP

. As a result, our attorneys

and legal staff have been able to recover more than $3 billion on behalf

of our clients. (c) 2015 Bernstein Liebhard LLP. Prior results do

not guarantee or predict a similar outcome with respect to any future

matter.

Contact Information: Sandy A. Bernstein Liebhard LLP

is the only firm in the country to be named to this prestigious list

every year since it was first published in 2003.

Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016

(888) 340-4807

ATTORNEY ADVERTISING. (Case

2:15-cv-00544-JEO) A second complaint filed in the U.S. Liebhard, Esq. As a

national law firm, Bernstein Liebhard LLP possesses all of the legal and

financial resources required to successfully challenge billion dollar

pharmaceutical and medical device companies. District Court, District of Massachusetts

claims that Zofran caused a baby girl to be born with a number of

congenital abnormalities, including heart defects. Food Drug Administration (FDA)

classifies the drug in Pregnancy Category B, which indicates that it has

not been well studied in pregnant women.

"One recent analysis found that ondansetron has been used to

treat roughly 1 million pregnant women every year.* In light of these

numbers, we would not be surprised if the Zofran litigation continues to

grow in the coming months," said Mr. (Case 1:15-cv-10429)

Two other children are alleged to have suffered Zofran-related heart

defects in a case that was filed on February 12[sup.th] in the U.S.

District Court, Eastern District of Pennsylvania. The complaints

further note that the U.S. Liebhard, a partner at Bernstein Liebhard

LLP, a nationwide law firm representing victims of defective drugs and

medical devices